Talisman Metals PUBLIC LIMITED COMPANY

Ovoca Bio is a clinical‑stage biopharmaceutical company founded and incorporated in Ireland, with operations across Ireland and the United Kingdom. The company is dedicated to improving women’s health by developing novel medicines that address high‑unmet medical needs. Its flagship product, Orenetide, is a first‑in‑class treatment aimed at pre‑menopausal women suffering from hypoactive sexual desire disorder (HSDD) – a condition that affects millions of women in both the United States and Europe.

Specialising in the research, development and commercialisation of innovative therapies for women, Ovoca Bio has already filed for marketing approval for Orenetide in the US and Europe and is actively seeking licensing or partnership opportunities with global pharmaceutical firms to accelerate patient access. Backed by a robust patent portfolio, the company’s vision is to become the partner of choice for novel medicines that tackle the most pressing gaps in women’s healthcare.